Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
McKesson
Baxter
Johnson and Johnson

Last Updated: April 7, 2020

DrugPatentWatch Database Preview

Formulation information for generic ingredient: apremilast


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Apremilast

CASRN: 608141-41-9

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Medtronic
Harvard Business School
Express Scripts
Johnson and Johnson